ImmunityBio IBRX Income Statement (2014-2026)

NASDAQ IBRX
$8.20 +0.01 (+0.12%)
As of: Sep 4, 2026 · 11:49 AM EDT
Reported Financials

ImmunityBio Quarterly Income Statement

Periods 50 quarters
Latest Jun 2026

ImmunityBio reported revenue of $51.24M and net income of -$230.39M for the quarter ended Jun 2026, up 93.9% year over year. This income statement covers 50 quarters of results from Mar 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
0.07M0.39M0.01M0.04M0.12M0.07M0.36M0.04M0.08M0.14M0.04M1.05M6.11M7.55M16.52M26.43M32.06M38.28M44.21M51.24M
Cost of RevenueCost of Rev
0.06M0.14M0.18M0.38M0.24M0.30M
Gross Profit
0.04M0.08M0.14M0.04M1.05M6.11M7.55M16.46M26.29M31.88M37.90M43.97M50.94M
Operating items
Research & DevelopmentR&D
49.28M51.75M55.38M63.08M71.61M58.08M79.26M53.17M48.40M51.53M53.35M51.13M50.44M35.22M48.23M55.24M51.23M63.86M67.99M60.82M
Selling, General & AdministrativeSG&A
29.62M27.91M40.61M16.57M19.31M26.21M32.68M32.02M31.82M33.11M41.88M49.25M35.92M41.73M32.65M42.34M36.28M38.73M45.77M51.82M
Other Operating ExpensesOther Opex
0.68M0.89M0.06M0.14M0.18M0.38M0.24M0.30M
Operating ExpensesOpex
78.90M79.66M95.99M79.66M90.92M84.97M111.94M85.19M80.22M85.53M95.24M100.38M86.36M76.95M80.95M97.71M87.69M102.97M114.00M112.94M
Operating IncomeOp. Inc
-78.84M-79.27M-95.97M-79.62M-90.80M-84.90M-111.58M-85.14M-80.14M-85.39M-95.20M-99.33M-80.25M-69.40M-64.43M-71.28M-55.63M-64.68M-69.79M-61.70M
EBIT
-78.84M-79.27M-95.97M-79.62M-90.80M-84.90M-111.58M-85.14M-80.14M-85.39M-95.20M-99.33M-80.25M-69.40M-64.43M-71.28M-55.63M-64.68M-69.79M-61.70M
Non-operating items
Non Operating Interest Expenses
3.61M4.49M8.49M9.70M16.76M28.56M29.82M32.23M35.02M0.40M29.46M29.79M29.32M26.02M15.31M15.47M15.26M14.84M14.59M14.05M
Non Operating Investment IncomeNon-Op. Investment Inc.
-5.94M-6.93M1.67M-1.80M0.86M-3.81M0.67M-0.06M0.04M0.48M3.10M1.89M1.80M1.19M0.89M1.15M2.07M2.30M2.31M3.15M
Interest & Investment IncomeInt & Inv Inc
Other Non Operating IncomeOther Non Op Inc.
-0.04M-0.06M-0.00M0.18M0.01M-0.92M-1.08M-0.03M-1.05M-0.07M-2.72M21.19M1.61M-6.61M5.58M1.93M0.29M-1.40M-5.92M-0.69M
Non Operating IncomeNon Op. Inc.
-9.59M-12.28M-7.03M-15.21M-20.36M-23.39M-5.00M-53.07M-15.51M-148.06M-38.93M-35.25M-5.50M10.22M-65.47M-21.02M-11.68M2.59M-563.00M-168.69M
Net income details
EBT
-88.43M-91.55M-103.00M-94.83M-111.16M-108.29M-116.58M-138.21M-95.64M-233.45M-134.13M-134.58M-85.75M-59.18M-129.90M-92.31M-67.31M-62.09M-632.79M-230.39M
Tax ProvisionsTaxes
0.00M0.03M-0.04M-0.23M0.30M-0.04M-0.14M0.01M
Profit After TaxPAT
-88.43M-91.55M-103.00M-94.83M-111.16M-108.33M-116.58M-138.21M-95.64M-233.41M-134.13M-134.58M-85.75M-59.18M-129.67M-92.57M-67.27M-61.96M-632.80M-230.39M
Equity Income
-0.80M-0.20M-3.90M-4.46M-3.55M-2.34M-3.96M-1.25M
Income from Non-Controlling InterestsInc. Minority
-0.80M-0.29M-0.17M-0.25M-0.22M-0.11M-0.24M-0.33M-0.06M-0.02M-0.02M-0.02M-0.02M-0.02M-0.02M-0.02M-0.02M-0.01M-0.01M-0.01M
Income from Continuing OperationsIncome (Continuing)
-88.43M-91.55M-103.00M-94.83M-111.16M-108.33M-116.58M-138.21M-95.64M-233.41M-134.13M-134.58M-85.75M-59.18M-129.67M-92.61M-67.27M-61.96M-632.80M-230.39M
Consolidated Net IncomeConsol Net Inc.
-88.43M-91.55M-103.00M-94.83M-111.16M-108.33M-116.58M-138.21M-95.64M-233.41M-134.13M-134.58M-85.75M-59.18M-129.67M-92.61M-67.27M-61.96M-632.80M-230.39M
Income towards Parent CompanyParent Net Inc
-88.43M-91.55M-103.00M-94.83M-111.16M-108.33M-116.58M-138.21M-95.64M-233.41M-134.13M-134.58M-85.75M-59.18M-129.67M-92.61M-67.27M-61.96M-632.80M-230.39M
Net Income towards Common StockholdersNet Income
-88.43M-91.55M-103.00M-94.83M-111.16M-108.33M-116.58M-138.21M-95.64M-233.41M-134.13M-134.58M-85.75M-59.18M-129.67M-92.61M-67.27M-61.96M-632.80M-230.39M
Additional items
EPS (Basic)
-0.23-0.24-0.26-0.24-0.28-0.27-0.27-0.32-0.19-0.46-0.20-0.20-0.12-0.08-0.15-0.10-0.07-0.07-0.62-0.22
EPS (Diluted)
-0.23-0.24-0.26-0.24-0.28-0.27-0.27-0.32-0.19-0.46-0.20-0.20-0.12-0.08-0.15-0.10-0.07-0.07-0.62-0.22
Shares Outstanding
391.85M389.23M397.88M397.99M400.06M399.90M428.38M437.46M498.38M508.64M672.83M686.94M695.89M697.31M853.16M888.22M946.60M919.86M1,026.87M1,050.07M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
391.85M389.23M397.88M397.99M400.06M399.90M428.38M437.46M498.38M508.64M672.83M686.94M697.96M700.44M853.16M888.22M946.60M919.86M1,026.87M1,050.07M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
394.51M397.83M397.96M398.07M400.30M421.57M421.57M440.67M498.38M508.64M677.00M691.79M696.83M697.31M853.56M915.63M984.97M1,011.80M1,047.34M1,053.22M
EBITDA
-78.84M-79.27M-95.97M-79.62M-90.80M-84.90M-111.58M-85.14M-80.14M-85.39M-95.20M-99.33M-80.25M-69.40M-64.43M-71.28M-55.63M-64.68M-69.79M-61.70M
Interest ExpensesInt Expense
3.61M4.49M8.49M9.70M16.76M28.56M29.82M32.23M35.02M0.40M29.46M29.79M29.32M26.02M15.31M15.47M15.26M14.84M14.59M14.05M
Tax Rate
0.00%-0.03%0.02%0.18%-0.33%0.05%0.22%0.00%